Cerenion C-Trend® featured in an article investigating sleep quality of intensive care patients

Cerenion C-Trend® was used in a scientific article entitled "Monitoring of nighttime EEG slow‐wave activity during dexmedetomidine infusion in patients with hyperactive ICU delirium: An observational pilot study" recently published in Acta Anaesthesiologica Scandinavica.
The disturbance of especially deep stages of sleep have been associated with intensive care unit (ICU) delirium, which is a sever condition of brain dysfunction associated with e.g. prolonged hospitalization, higher mortality, and long-term cognitive impairment. Monitoring and improving the sleep quality in the ICU potentially reduces the risk of delirium. In the published pilot study, C-Trend® was used for objective evaluation of slow-wave activity, an EEG feature occurring during deep sleep, in ICU patients diagnosed with hyperactive delirium. The study confirmed previous findings of poor sleep quality in these patients and emphasized the necessity of objective sleep evaluation during intensive care.
The study was carried out in collaboration with Oulu University Hospital and University of Oulu and is available as open access at: https://doi.org/10.1111/aas.14131.
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2024 Cerenion Oy